These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31565245)

  • 1. EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases.
    Najm A; Nikiphorou E; Kostine M; Richez C; Pauling JD; Finckh A; Ritschl V; Prior Y; Balážová P; Stones S; Szekanecz Z; Iagnocco A; Ramiro S; Sivera F; Dougados M; Carmona L; Burmester G; Wiek D; Gossec L; Berenbaum F
    RMD Open; 2019; 5(2):e001014. PubMed ID: 31565245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review.
    Najm A; Gossec L; Weill C; Benoist D; Berenbaum F; Nikiphorou E
    JMIR Mhealth Uhealth; 2019 Nov; 7(11):e14730. PubMed ID: 31769758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
    Boonen A; Webers C; Butink M; Barten B; Betteridge N; Black DC; Bremander A; Boteva B; Brzezińska O; Chauhan L; Copsey S; Guimarães V; Gignac M; Glaysher J; Green F; Hoving JL; Marques ML; Smucrova H; Stamm TA; Wiek D; Wilkie R; Woolf AD; Burmester GR; Bijlsma JW; Verstappen SMM
    Ann Rheum Dis; 2023 Jan; 82(1):57-64. PubMed ID: 36109139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Needs, Experiences, and Views of People With Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health Apps: Mixed Methods Study.
    Najm A; Lempp H; Gossec L; Berenbaum F; Nikiphorou E
    JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14351. PubMed ID: 32310151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases.
    de Thurah A; Bosch P; Marques A; Meissner Y; Mukhtyar CB; Knitza J; Najm A; Østerås N; Pelle T; Knudsen LR; Šmucrová H; Berenbaum F; Jani M; Geenen R; Krusche M; Pchelnikova P; de Souza S; Badreh S; Wiek D; Piantoni S; Gwinnutt JM; Duftner C; Canhão HM; Quartuccio L; Stoilov N; Prior Y; Bijlsma JW; Zabotti A; Stamm TA; Dejaco C
    Ann Rheum Dis; 2022 Aug; 81(8):1065-1071. PubMed ID: 35470160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs).
    Dejaco C; Machado PM; Carubbi F; Bosch P; Terslev L; Tamborrini G; Sconfienza LM; Scirè CA; Ruetten S; van Rompay J; Proft F; Pitzalis C; Obradov M; Moe RH; Mascarenhas VV; Malattia C; Klauser AS; Kent A; Jans L; Hartung W; Hammer HB; Duftner C; Balint PV; Alunno A; Baraliakos X
    Ann Rheum Dis; 2022 Jun; 81(6):760-767. PubMed ID: 34893469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a systematic literature review of smartphone apps to support the self-management of rheumatic and musculoskeletal diseases: development strategies, theoretical underpinnings and barriers to engagement.
    Barnett R; Clarke C; Sengupta R; Rouse PC
    Syst Rev; 2023 Jul; 12(1):129. PubMed ID: 37516896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice.
    Ritschl V; Stamm TA; Aletaha D; Bijlsma JWJ; Böhm P; Dragoi RG; Dures E; Estévez-López F; Gossec L; Iagnocco A; Marques A; Moholt E; Nudel M; van den Bemt BJF; Viktil K; Voshaar M; de Thurah A; Carmona L
    Ann Rheum Dis; 2021 Jun; 80(6):707-713. PubMed ID: 33355152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases.
    Gossec L; Kedra J; Servy H; Pandit A; Stones S; Berenbaum F; Finckh A; Baraliakos X; Stamm TA; Gomez-Cabrero D; Pristipino C; Choquet R; Burmester GR; Radstake TRDJ
    Ann Rheum Dis; 2020 Jan; 79(1):69-76. PubMed ID: 31229952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.
    Krieckaert CL; van Tubergen A; Gehin JE; Hernández-Breijo B; Le Mélédo G; Balsa A; Böhm P; Cucnik S; Elkayam O; Goll GL; Hooijberg F; Jani M; Kiely PD; McCarthy N; Mulleman D; Navarro-Compán V; Payne K; Perry ME; Plasencia-Rodriguez C; Stones SR; Syversen SW; de Vries A; Ward KM; Wolbink G; Isaacs JD
    Ann Rheum Dis; 2023 Jan; 82(1):65-73. PubMed ID: 35551063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
    Rodríguez-Carrio J; Burska A; Conaghan PG; Dik WA; Biesen R; Eloranta ML; Cavalli G; Visser M; Boumpas DT; Bertsias G; Wahren-Herlenius M; Rehwinkel J; Frémond ML; Crow MK; Rönnblom L; Versnel MA; Vital EM
    Ann Rheum Dis; 2023 Jun; 82(6):754-762. PubMed ID: 36858821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
    Dures E; Farisoğulları B; Santos EJF; Molto A; Feldthusen C; Harris C; Elling-Audersch C; Connolly D; Elefante E; Estévez-López F; Bini I; Primdahl J; Hoeper K; Urban M; van de Laar MAFJ; Redondo M; Böhm P; Amarnani R; Hayward R; Geenen R; Rednic S; Pettersson S; Thomsen T; Uhlig T; Ritschl V; Machado PM
    Ann Rheum Dis; 2024 Sep; 83(10):1260-1267. PubMed ID: 38050029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey.
    Iagnocco A; Ciccia F; Conti F; D'Angelo S; Epis OM; Govoni M; Guiducci S; Iannone F; Mosca M; Salaffi F; Sebastiani GD; Sonnati M; Caporali RF
    Clin Exp Rheumatol; 2023 Sep; 41(9):1917-1925. PubMed ID: 37382465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.
    Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R
    Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile Health Apps on COVID-19 Launched in the Early Days of the Pandemic: Content Analysis and Review.
    Ming LC; Untong N; Aliudin NA; Osili N; Kifli N; Tan CS; Goh KW; Ng PW; Al-Worafi YM; Lee KS; Goh HP
    JMIR Mhealth Uhealth; 2020 Sep; 8(9):e19796. PubMed ID: 32609622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.
    Al Maini M; Adelowo F; Al Saleh J; Al Weshahi Y; Burmester GR; Cutolo M; Flood J; March L; McDonald-Blumer H; Pile K; Pineda C; Thorne C; Kvien TK
    Clin Rheumatol; 2015 May; 34(5):819-29. PubMed ID: 25501633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
    Gwinnutt JM; Wieczorek M; Rodríguez-Carrio J; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda M; Guillemin F; Verstappen SMM
    RMD Open; 2022 Jun; 8(2):. PubMed ID: 35654458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology.
    Dejaco C; Putrik P; Unger J; Aletaha D; Bianchi G; Bijlsma JW; Boonen A; Cikes N; Finckh A; Gossec L; Kvien TK; Madruga Dias J; Matteson EL; Sivera F; Stamm TA; Szekanecz Z; Wiek D; Zink A; Ramiro S; Buttgereit F
    RMD Open; 2018; 4(2):e000780. PubMed ID: 30714579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobile health technologies for the management of rheumatic diseases: a systematic review of online stores in Brazil.
    Dantas LO; Carvalho C; Prando BC; McAlindon TE; da Silva Serrão PRM
    Clin Rheumatol; 2021 Jul; 40(7):2601-2609. PubMed ID: 33389312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2019 EULAR points to consider for the assessment of competences in rheumatology specialty training.
    Sivera F; Alunno A; Najm A; Avcin T; Baraliakos X; Bijlsma JW; Badreh S; Burmester G; Cikes N; Da Silva JA; Damjanov N; Dougados M; Dudler J; Edwards CJ; Iagnocco A; Lioté F; Nikiphorou E; van Onna M; Stones SR; Vassilopoulos D; Haines C; Ramiro S
    Ann Rheum Dis; 2021 Jan; 80(1):65-70. PubMed ID: 32788400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.